The Leadership Meeting – Where Leaders Go To Learn
Rob Wright provides a high-level overview of The Leadership Meeting, a pre-JPM conference with content specifically curated for professional development of c-level life science leaders. Continue Reading..
Brightspot: How A Biopharma VC Makes A Difference For Orphans
Ed Torres, managing partner at Lilly Ventures, shares how he and his wife got involved in making a difference for U.S. orphans. Continue Reading..
The CNS Summit — A Caring Community Of Collaborative Solution Finders
Chief editor Rob Wright explains what differentiates the CNS Summit from other biopharmaceutical industry conferences. Continue Reading..
Making A Difference For Veterans: A Biopharma Bright Spot
The little known story of an immigrant couple making a $15 million difference for U.S. veterans. Continue Reading..
Negative Perceptions Of Biopharma — Let’s Get The Ugly On The Table
A Life Science Leader reader shares their thoughts on why the biopharmaceutical industry’s reputation is so dismal, but also proposes solutions for how to repair it. Continue Reading..
Want To Start Fixing Biopharma’s Reputation? Let’s Start By Sharing More Biopharma Brightspots
With the biopharmaceutical industry’s reputation at an all-time low, Life Science Leader’s Rob Wright looks to share little-known stories of the good being done by employees of biopharma. This first installment involves Antoine Yver, M.D., EVP and global head of R&D at Daiichi Sankyo, who helped to cofound a 501(c)3 nonprofit restaurant, The Blue Bears Special Meals. Continue Reading..
Have We Seen The End Of Competitive Advantage?
Thinker50 member and Columbia Business School Professor Rita Gunther McGrath, Ph.D., believes we have seen the end of sustainable competitive advantage, but has some solutions for businesses open to building strategies around transient competitive advantage. Continue Reading..
Biopharma’s Reputation — Out Of The Frying Pan And Into The Fire
Chief Editor Rob Wright discusses the implications of the recent Gallup poll indicating pharma presently being the most poorly regarded of all industries in the eyes of Americans. Continue Reading..
The Opioid Addiction Crisis — A Historical View From The Front Lines
Chief Editor Rob Wright saw glimpses into the impending opioid crisis back when he was working as a pharma sales rep in the pain management space. Continue Reading..
Is It Time To Throw In The Towel On Biosimilars In The U.S.?
Rob Wright takes issue with Peter Bach, M.D., and Mark Trusheim’s recommendation that the U.S. would be better served by abandoning continued biosimilar drug development. Continue Reading..